Status:
COMPLETED
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
Lead Sponsor:
Pfizer
Conditions:
Growth Disorders
Eligibility:
All Genders
3-7 years
Phase:
PHASE3
Brief Summary
The primary objective is to evaluate, if Genotonorm (Genotropin) increases linear growth in short children born SGA. Safety of the drug is a main objective as well. The growth promoting effect of two ...
Eligibility Criteria
Inclusion
- Birth length below -2 SD
- Height at start below - 2 Sd
Exclusion
- Any endocrine or chronic disease
- Any known syndrome with short stature
Key Trial Info
Start Date :
March 1 1990
Trial Type :
INTERVENTIONAL
End Date :
February 1 2005
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00174408
Start Date
March 1 1990
End Date
February 1 2005
Last Update
May 3 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.